USPTO serial 79377826
DEGLUSTEROL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 9, 2024
- Examiner
- HUDSON, TAMARA BREE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DEGLUSTEROL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Miriam D. Trudell
Miriam D. Trudell Davis Graham & Stubbs LLC3400 Walnut Street, Suite 700Denver, CO 80205United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biomedical compounds, namely, peptides for industrial purposes; oligopeptides for industrial purposes; biomedical compounds, namely, peptide substrates for scientific purposes; biomedical compounds, namely, peptides for laboratory or research use, other than for medical purposes; peptides being raw materials for industrial use for dietetic purposes, other than for medical purposes; proteins for use in the manufacture of food supplements; proteins for the food industry; enzymes for industrial purposes; proteins for industrial use; proteins being raw material for industrial use; proteins for use in the manufacture of food and beverages; proteins for use in manufacture; proteins for use in the manufacture of cosmetics; chemicals used in industry and science; biochemical preparations for scientific purposes; biomedical compounds, namely, synthetic peptides for use in the manufacture of food supplements for blood sugar management; cultures of microorganisms, other than for medical and veterinary use; chemical additives for use in the manufacture of food; enzymes for the food industry; amino acids for industrial purposes, namely, for laboratory or research use | ACTIVE | — |
| 005 | Nutraceutical preparations for blood sugar control; nutraceuticals for use as a dietary supplement; biochemical preparations for medical or veterinary purposes for the treatment of diabetes; biotechnological preparations for medical purposes for the treatment of diabetes; powdered nutritional supplement drink mixes; pharmacological preparations for skin care; pharmaceuticals for the treatment of diabetes; medical preparations for slimming purposes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hyperlipidemia; anti-diabetic pharmaceuticals; pharmaceutical preparations for health care for the treatment of diabetes; pharmaceutical preparations for the prevention of diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for treating hypoglycemia; hypoglycemic agents; synthetic peptides for pharmaceutical purposes for the treatment of diabetes; medicines for human purposes for the treatment of diabetes; seaweed-based dietary supplements for diabetics; vegetables-based dietary supplements for diabetics; dietary supplements for diabetics based on Chinese matrimony vine; dietary supplements for diabetics based on the root of arrowroots; dietary supplements for diabetics based on Solomon's seal; meat-based dietary supplements for diabetics; whey-based dietary supplements for diabetics; dietary supplements for diabetics based on processed oils and fats for food; dietary supplements for diabetics based on preserved fish; dietary supplements for diabetics based on processed algae | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CAREGEN CO., LTD.
- Other trademarks owned by CAREGEN CO., LTD.
- Other trademarks owned by CAREGEN CO., LTD.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named DEGLUSTEROL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 15, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 27, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 26, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 25, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 3, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 3, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 14, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 14, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Nov 14, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 14, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 20, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 9, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 9, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 23, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 23, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 3, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 14, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 9, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 8, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 8, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 7, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 13, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 13, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 28, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 27, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 9, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 5, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 31, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |